FY24 Annual Report to Shareholders
Investor Relations
Corporate Governance
Cogstate's Board and management are committed to shareholder value
Board of Directors
Meet the Cogstate Board of Directors who bring a wealth of knowledge and experience to our business
Financial Reports
See our Annual and Half Year reports
Investor Presentations
View Cogstate's recent investor presentations
Financial Calendar
View our upcoming financial events
Shareholder Information
See information on Cogstate's shareholder services
Learn About Cogstate
Cogstate digital technology provides rapid, reliable, and sensitive computerized assessment of cognition. For 20 years, the company has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions and the clinical care needs of physicians and patients around the world.
Cogstate Highlights
Cogstate’s easy-to-use, digital cognitive assessments are based on science which has been widely accepted and validated both academically and commercially through hundreds of peer-reviewed publications
Cogstate solutions serve three distinct markets: Clinical Trials, Healthcare and Academic Research
Cogstate has a history of strong financial performance with the Clinical Trials business enabling the company to self-fund R&D and commercialisation opportunities
Cogstate leverages its leading expertise in cognitive testing to penetrate growing markets in Healthcare and Brain Injury
